Pediatric neurodegenerative white matter processes: Leukodystrophies and beyond

Pediatric Radiology

Volumn 38, Issue 7, 2008, Pages 729-749

  Phelan, Jonathan A ^a   Lowe, Lisa H ^b   Glasier, Charles M ^c  

^a KANSAS CITY UNIVERSITY OF MEDICINE AND BIOSCIENCES   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Leukodystrophies; MRI; Pediatric neuroimaging; White matter

Indexed keywords

ALEXANDER DISEASE; CANAVAN DISEASE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; ENCEPHALOMALACIA; GALACTOSEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; INBORN ERROR OF METABOLISM; INFLAMMATION; KEARNS SAYRE SYNDROME; LEUKODYSTROPHY; MACROCEPHALY; METABOLIC DISORDER; MUCOPOLYSACCHARIDOSIS; NERVE DEGENERATION; NEUROIMAGING; PRIORITY JOURNAL; REVIEW; WALKER WARBURG SYNDROME; WHITE MATTER;

CHILD; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEURODEGENERATIVE DISEASES;

EID: 45449103846     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-008-0817-x     Document Type: Review

References (96)

1. Kristjansdottir R, Uvebrant P, Hagberg B et al (1996) Disorders of the cerebral white matter in children. The spectrum of lesions. Neuropediatrics 27:295-298
2. van der Knaap MS, Breiter SN, Naidu S et al (1999) Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology 213:121-133
3. Barkovich AJ (2005) Pediatric neuroimaging. Lippincott Williams and Wilkins, Philadelphia, pp 76-187
4. Van der Knaap MS, Valk J (2005) Magnetic resonance of myelination and myelin disorders. Springer-Verlag, Heidelberg
5. Haynes RL, Baud O, Li J et al (2005) Oxidative and nitrative injury in periventricular leukomalacia: a review. Brain Pathol 15:225-233
6. Idrissova Zh R, Boldyreva MN, Dekonenko EP et al (2003) Acute disseminated encephalomyelitis in children: clinical features and HLA-DR linkage. Eur J Neurol 10:537-546
7. Menge T, Kieseier BC, Nessler S et al (2007) Acute disseminated encephalomyelitis: an acute hit against the brain. Curr Opin Neurol 20:247-254
8. Baum PA, Barkovich AJ, Koch TK et al (1994) Deep gray matter involvement in children with acute disseminated encephalomyelitis. AJNR 15:1275-1283
9. Honkaniemi J, Dastidar P, Kahara V et al (2001) Delayed MR imaging changes in acute disseminated encephalomyelitis. AJNR 22:1117-1124
10. American Academy of Pediatrics Committee on Infectious Diseases (2000) Prevention of Lyme disease. Pediatrics 105:142-147
11. Hoppa E, Bachur R (2007) Lyme disease update. Curr Opin Pediatr 19:275-280
12. Pachner AR, Steiner I (2007) Lyme neuroborreliosis: infection, immunity, and inflammation. Lancet Neurol 6:544-552
13. Cheon JE, Kim IO, Hwang YS et al (2002) Leukodystrophy in children: a pictorial review of MR imaging features. Radiographics 22:461-476
14. Brenner M, Johnson AB, Boespflug-Tanguy O et al (2001) Mutations in GFAP, encoding glial fibrillary acidic protein associated with Alexander disease. Nat Genet 27:117-120
15. Sener RN (2001) Demonstration of glycine peaks at 3.50 ppm in a patient with van der Knaap syndrome. AJNR 22:1587-1589
16. Matalon R, Michals K, Sebesta D et al (1988) Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet 29:463-471
17. Brismar J, Brismar G, Gascon G et al (1990) Canavan disease: CT and MR imaging of the brain. AJNR 11:805-810
18. Grodd W, Krageloh-Mann I, Petersen D et al (1990) In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet 336:437-438
19. Topcu M, Gartioux C, Ribierre F et al (2000) Vacuoliting megalencephalic leukoencephalopathy with subcortical cysts, mapped to chromosome 22qtel. Am J Hum Genet 66:733-739
20. van der Knaap MS, Barth PG, Vrensen GF et al (1996) Histopathology of an infantile-onset spongiform leukoencephalopathy with a discrepantly mild clinical course. Acta Neuropathol 92:206-212
21. Gelal F, Calli C, Apaydin M et al (2002) van der Knaap's leukoencephalopathy: report of five new cases with emphasis on diffusion-weighted MRI findings. Neuroradiology 44:625-630
22. van der Knaap MS, Kamphorst W, Barth PG et al (1998) Phenotypic variation in leukoencephalopathy with vanishing white matter. Neurology 51:540-547
23. van der Voorn JP, van Kollenburg B, Bertrand G et al (2005) The unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol 64:770-775
24. Donnell GN, Collado M, Koch R (1961) Growth and development of children with galactosemia. J Pediatr 58:836-844
25. Nelson MD Jr, Wolff JA, Cross CA et al (1992) Galactosemia: evaluation with MR imaging. Radiology 184:255-261
26. Otaduy MC, Leite CC, Lacerda MT et al (2006) Proton MR spectroscopy and imaging of a galactosemic patient before and after dietary treatment. AJNR 27:204-207
27. Munoz A, Mateos F, Simon R et al (1999) Mitochondrial diseases in children: neuroradiological and clinical features in 17 patients. Neuroradiology 41:920-928
28. Chu BC, Terae S, Takahashi C et al (1999) MRI of the brain in the Kearns-Sayre syndrome: report of four cases and a review. Neuroradiology 41:759-764
29. Seigel RS, Seeger JF, Gabrielsen TO et al (1979) Computed tomography in oculocraniosomatic disease (Kearns-Sayre syndrome). Radiology 130:159-164
30. Dinopoulos A, Cecil KM, Schapiro MB et al (2005) Brain MRI and proton MRS findings in infants and children with respiratory chain defects. Neuropediatrics 36:290-301
31. Barkovich AJ, Good WV, Koch TK et al (1993) Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR 14:1119-1137
32. Itoh K, Kase R, Shimmoto M et al (1995) Protective protein as an endogenous endothelin degradation enzyme in human tissues. J Biol Chem 270:515-518
33. Chen CY, Zimmerman RA, Lee CC et al (1998) Neuroimaging findings in late infantile GM1 gangliosidosis. AJNR 19:1628-1630
34. Pavlu J, Jackson M, Panoskaltsis N (2006) GM1-gangliosidosis type I. Br J Haematol 135:422
35. Patay Z (2005) Diffusion-weighted MR imaging in leukodystrophies. Eur Radiol 15:2284-2303
36. Koelfen W, Freund M, Jaschke W et al (1994) GM-2 gangliosidosis (Sandhoff's disease): two-year follow-up by MRI. Neuroradiology 36:152-154
37. Marsden DL, Nyhan WL (1992) Neurological diseases in disorders of organic acids. Curr Opin Neurol Neurosurg 5:349-354
38. Kaur M, Verma IC (1995) Enzyme studies in GM2 gangliosidosis, and their application in prenatal diagnosis. Ind J Pediatr 62:485-489
39. Mugikura S, Takahashi S, Higano S et al (1996) MR findings in Tay-Sachs disease. J Comput Assist Tomogr 20:551-555
40. Inglese M, Nusbaum AO, Pastores GM et al (2005) MR imaging and proton spectroscopy of neuronal injury in late-onset GM2 gangliosidosis. AJNR 26:2037-2042
41. Loes DJ, Peters C, Krivit W (1999) Globoid cell leukodystrophy: distinguishing early-onset from late-onset disease using a brain MR imaging scoring method. AJNR 20:316-323
42. Choi S, Enzmann DR (1993) Infantile Krabbe disease: complementary CT and MR findings. AJNR 14:1164-1166
43. Brockmann K, Dechent P, Wilken B et al (2003) Proton MRS profile of cerebral metabolic abnormalities in Krabbe disease. Neurology 60:819-825
44. Moser HW, Loes DJ, Melhem ER (2000) X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics 31:227-239
45. van Geel BM, Bezman L, Loes DJ et al (2001) Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol 49:186-194
46. Stephenson DJ, Bezman L, Raymond GV (2000) Acute presentation of childhood adrenoleukodystrophy. Neuropediatrics 31:293-297
47. Moser HW (1997) Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain 120(8):1485-1508
48. Moser HW, Moser AB (1996) Peroxisomal disorders: overview. Ann N Y Acad Sci 804:427-441
49. Melhem ER, Loes DJ, Georgiades CS et al (2000) X-linked adrenoleukodystrophy: the role of contrast-enhanced MR imaging in predicting disease progression. AJNR 21:839-844
50. Barkovich AJ, Ferriero DM, Bass N et al (1997) Involvement of the pontomedullary corticospinal tracts: a useful finding in the diagnosis of X-linked adrenoleukodystrophy. AJNR 18:95-100
51. Eichler FS, Itoh R, Barker PB et al (2002) Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology 225:245-252
52. Brismar J, Aqeel A, Brismar G et al (1990) Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants. AJNR 11:1219-1228
53. Fariello G, Dionisi-Vici C, Orazi C et al (1996) Cranial ultrasonography in maple syrup urine disease. AJNR 17:311-315
54. Cavalleri F, Berardi A, Burlina AB et al (2002) Diffusion-weighted MRI of maple syrup urine disease encephalopathy. Neuroradiology 44:499-502
55. Heindel W, Kugel H, Wendel U et al (1995) Proton magnetic resonance spectroscopy reflects metabolic decompensation in maple syrup urine disease. Pediatr Radiol 25:296-299
56. Kingsley PB, Shah TC, Woldenberg R (2006) Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy. NMR Biomed 19:435-462
57. Kim TS, Kim IO, Kim WS et al (1997) MR of childhood metachromatic leukodystrophy. AJNR 18:733-738
58. Sener RN (2003) Metachromatic leukodystrophy. Diffusion MR imaging and proton MR spectroscopy. Acta Radiol 44:440-443
59. Watts RW, Spellacy E, Kendall BE et al (1981) Computed tomography studies on patients with mucopolysaccharidoses. Neuroradiology 21:9-23
60. Tzika AA, Ball WS Jr, Vigneron DB et al (1993) Clinical proton MR spectroscopy of neurodegenerative disease in childhood. AJNR 14:1267-1281; discussion 1282-1284
61. Suchy SF, Olivos-Glander IM, Nussabaum RL (1995) Lowe syndrome, a deficiency of phosphatidylinositol 4,5-bisphosphate 5-phosphatase in the Golgi apparatus. Hum Mol Genet 4:2245-2250
62. Lowe CU, Terrey M, MacLachlan EA (1952) Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation: a clinical entity. AMA Am J Dis Child 83:164-184
63. Carroll WJ, Woodruff WW, Cadman TE (1993) MR findings in oculocerebrorenal syndrome. AJNR 14:449-451
64. Schneider JF, Boltshauser E, Neuhaus TJ et al (2001) MRI and proton spectroscopy in Lowe syndrome. Neuropediatrics 32:45-48
65. Kim DS, Hayashi YK, Matsumoto H et al (2004) POMT1 mutation results in defective glycosylation and loss of laminin-binding activity in alpha-DG. Neurology 62:1009-1011
66. Kanoff RJ, Curless RG, Petito C et al (1998) Walker-Warburg syndrome: neurologic features and muscle membrane structure. Pediatr Neurol 18:76-80
67. Muntoni F, Brockington M, Torelli S et al (2004) Defective glycosylation in congenital muscular dystrophies. Curr Opin Neurol 17:205-209
68. Martin-Rendon E, Blake DJ (2003) Protein glycosylation in disease: new insights into the congenital muscular dystrophies. Trends Pharmacol Sci 24:178-183
69. Dobyns WB, Pagon RA, Armstrong D et al (1989) Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 32:195-210
70. Fukuyama Y, Osawa M, Suzuki H (1981) Congenital progressive muscular dystrophy of the Fukuyama type - clinical, genetic and pathological considerations. Brain Dev 3:1-29
71. Kondo-Iida E, Kobayashi K, Watanabe M et al (1999) Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD). Hum Mol Genet 8:2303-2309
72. Aida N (1998) Fukuyama congenital muscular dystrophy: a neuroradiologic review. J Magn Reson Imaging 8:317-326
73. Aida N, Tamagawa K, Takada K et al (1996) Brain MR in Fukuyama congenital muscular dystrophy. AJNR 17:605-613
74. Aida N, Yagishita A, Takada K et al (1994) Cerebellar MR in Fukuyama congenital muscular dystrophy: polymicrogyria with cystic lesions. AJNR 15:1755-1759
75. Santavuori P, Somer H, Sainio K et al (1989) Muscle-eye-brain disease (MEB). Brain Dev 11:147-153
76. Santavuori P, Valanne L, Autti T et al (1998) Muscle-eye-brain disease: clinical features, visual evoked potentials and brain imaging in 20 patients. Eur J Paediatr Neurol 2:41-47
77. Valanne L, Pihko H, Katevuo K et al (1994) MRI of the brain in muscle-eye-brain (MEB) disease. Neuroradiology 36:473-476
78. Faerber EN, Poussaint TY (2002) Magnetic resonance of metabolic and degenerative diseases in children. Top Magn Reson Imaging 13:3-21
79. Barkovich AJ, Peck WW (1997) MR of Zellweger syndrome. AJNR 18:1163-1170
80. Powers JM (1995) The pathology of peroxisomal disorders with pathogenetic considerations. J Neuropathol Exp Neurol 54:710-719
81. Poggi-Travert F, Fournier B, Poll-The BT et al (1995) Clinical approach to inherited peroxisomal disorders. J Inherit Metab Dis 18 [Suppl 1]:1-18
82. Paprocka J, Jamroz E, Adamek D et al (2007) Clinical and neuropathological picture of familial encephalopathy with bifunctional protein deficiency. Folia Neuropathol 45:213-219
83. Jose da Rocha A, Tulio Braga F, Carlos Martins Maia A Jr et al (2008) Lactate detection by MRS in mitochondrial encephalopathy: optimization of technical parameters. J Neuroimaging 18:1-8
84. Majoie CB, Akkerman EM, Blank C et al (2002) Mitochondrial encephalomyopathy: comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: case report. AJNR 23:813-816
85. Ohama E, Ohara S, Ikuta F et al (1987) Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 74:226-233
86. Bianchi MC, Sgandurra G, Tosetti M et al (2007) Brain magnetic resonance in the diagnostic evaluation of mitochondrial encephalopathies. Biosci Rep 27:69-85
87. Pavlakis SG, Kingsley PB, Kaplan GP et al (1998) Magnetic resonance spectroscopy: use in monitoring MELAS treatment. Arch Neurol 55:849-852
88. Israels S, Haworth JC, Dunn HG et al (1976) Lactic acidosis in childhood. Adv Pediatr 22:267-303
89. DiMauro S, Andreu AL, De Vivo DC (2002) Mitochondrial disorders. J Child Neurol 17 [Suppl 3]:3S35-3S45; discussion 3S46-3S47
90. Sazgar M, Robinson JL, Chan AK et al (2003) Influenza B acute necrotizing encephalopathy: a case report and literature review. Pediatr Neurol 28:396-399
91. Arii J, Tanabe Y (2000) Leigh syndrome: serial MR imaging and clinical follow-up. AJNR 21:1502-1509
92. Crimi M, Papadimitriou A, Galbiati S et al (2004) A new mitochondrial DNA mutation in ND3 gene causing severe Leigh syndrome with early lethality. Pediatr Res 55:842-846
93. Savoiardo M, Ciceri E, D'Incerti L et al (1995) Symmetric lesions of the subthalamic nuclei in mitochondrial encephalopathies: an almost distinctive mark of Leigh disease with COX deficiency. AJNR 16:1746-1747
94. Detre JA, Wang ZY, Bogdan AR et al (1991) Regional variation in brain lactate in Leigh syndrome by localized 1H magnetic resonance spectroscopy. Ann Neurol 29:218-221
95. Grodd W, Krageloh-Mann I, Klose U et al (1991) Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. Radiology 181:173-181
96. Krageloh-Mann I, Grodd W, Schoning M et al (1993) Proton spectroscopy in five patients with Leigh's disease and mitochondrial enzyme deficiency. Dev Med Child Neurol 35:769-776